Dose intensification of chemotherapy and the role of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in small cell lung cancer

An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn.

Tjan-Heijnen, V.C.
Wagener, D.J.T.
Postmus, P.E.

January 2002

Item does not contain fulltextBACKGROUND: The survival in untreated small-cell lung cancer (SCLC) is...

Review of the value of colony stimulating factors for prophylaxis of febrile neutropenic episodes in adult patients treated for haematological malignancies.

Levenga, T.H.
Timmer-Bonte, J.N.H.

January 2007

Contains fulltext : 51747timmer-bonte.pdf (publisher's version ) (Closed access)Ch...

Prophylactic G-CSF and antibiotics enable a significant dose-escalation of triplet-chemotherapy in non-small cell lung cancer.

Timmer-Bonte, J.N.H.
Punt, C.J.A.
Heijden, H.F.M. van der
Die, C.E. van
Bussink, J.
Beijnen, J.H.
Huitema, A.D.
Tjan-Heijnen, V.C.

January 2008

Contains fulltext : 71334.pdf (publisher's version ) (Closed access)In advanced no...

Dose and dose-intensity of chemotherapy, studies in small cell lung cancer

Tjan-Heijnen, Vivianne Christine Gerarda

January 2002

Contains fulltext : 19175_doseandoi.pdf (publisher's version ) (Open Access)Withou...

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

Ardizzoni, A.
Tjan-Heijnen, V.C.
Postmus, P.E.
Buchholz, E.
Biesma, B.
Karnicka-Mlodkowska, H.
Dziadziuszko, R.
Burghouts, J.T.M.
Meerbeeck, J.P. van
Gans, S.
Legrand, C.
Debruyne, C.
Giaccone, G.
Manegold, C.

January 2002

Item does not contain fulltextPURPOSE: To assess the impact on survival of increasing dose-intensity...

Received Dose-Intensity: A Randomized Trial of Weekly Chemotherapy With and Without Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer

R. L. Souhami
P. G. Harper

October 2016

Purpose: A prospective randomized trial to deter-mine if granulocyte colony-stimulating factor (G-CS...

Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.

Timmer-Bonte, J.N.H.
Tjan-Heijnen, V.C.

January 2006

Contains fulltext : 49340timmer-bonte.pdf (publisher's version ) (Closed access

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia

Vellenga, E.
Uyl-de Groot, C.A.
Wit, R. de
Keizer, H.J.
Löwenberg, B.
Haaft, M.A. ten
Witte, T.J.M. de
Verhagen, C.A.H.
Stoter, G.J.
Rutten, F.F.H.
Mulder, N.H.
Smid, W.M.
Vries, E.G.E. de

January 1996

Contains fulltext : 22848___.PDF (publisher's version ) (Open Access

Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor

Gurney, H.
Anderson, H.
Radford, J.
Potter, M. R.
Swindell, R.
Steward, W.
Kamthan, A.
Chang, J.
Weiner, J.
Thatcher, N.
Crowther, D.

January 1992

The effect of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) was assess...

Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy?

Croockewit, A.J.
Koopmans, P.P.
Pauw, B.E. de

January 1996

Contains fulltext : 22983___.PDF (publisher's version ) (Open Access

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for research and treatment of cancer leukemia cooperative group

Zittoun, R.
Suciu, S.
Mandelli, F.
Witte, T.J.M. de
Thaler, J.
Stryckmans, P.
Hayat, M.
Peetermans, M.
Cadiou, M.
Solbu, G.
Petti, M.C.
Willemze, R.

January 1996

Contains fulltext : 23963___.PDF (publisher's version ) (Open Access

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.

Aapro, M.S.
Cameron, D.
Pettengell, R.
Bohlius, J.
Crawford, J.
Ellis, M.
Kearney, N.
Lyman, G.H.
Tjan-Heijnen, V.C.
Walewski, J.A.
Weber, D.C.
Zielinski, C.

January 2006

Contains fulltext : 50078tjan-heijnen.pdf (publisher's version ) (Closed access)Ch...

Supplemental material for Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level

Hassam Baig (5741096)
Barbara Somlo (5741099)
Melissa Eisen (2544973)
Scott Stryker (5741102)
Mark Bensink (799890)
Phuong K Morrow (5741105)

September 2018

Supplemental material for Appropriateness of granulocyte colony-stimulating factor use in patients r...

Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.

Timmer-Bonte, A.
Boo, T.M. de
Smit, H.J.
Biesma, B.
Wilschut, F.A.
Cheragwandi, S.A.
Termeer, A.
Hensing, C.A.
Akkermans, J.
Adang, E.M.M.
Bootsma, G.P.
Tjan-Heijnen, V.C.

January 2005

Contains fulltext : 47915_pub.pdf (publisher's version ) (Closed access) ...

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

Ardizzoni, A.
Tjan-Heijnen, V.C.
Postmus, P.E.
Buchholz, E.
Biesma, B.
Karnicka-Mlodkowska, H.
Dziadziuszko, R.
Burghouts, J.T.M.
Meerbeeck, J.P. van
Gans, S.
Legrand, C.
Debruyne, C.
Giaccone, G.
Manegold, C.

January 2002

PURPOSE: To assess the impact on survival of increasing dose-intensity (DI) of cyclophosphamide, dox...

An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn.

Tjan-Heijnen, V.C.
Wagener, D.J.T.
Postmus, P.E.

January 2002

Item does not contain fulltextBACKGROUND: The survival in untreated small-cell lung cancer (SCLC) is...

Review of the value of colony stimulating factors for prophylaxis of febrile neutropenic episodes in adult patients treated for haematological malignancies.

Levenga, T.H.
Timmer-Bonte, J.N.H.

January 2007

Contains fulltext : 51747timmer-bonte.pdf (publisher's version ) (Closed access)Ch...

Prophylactic G-CSF and antibiotics enable a significant dose-escalation of triplet-chemotherapy in non-small cell lung cancer.

Timmer-Bonte, J.N.H.
Punt, C.J.A.
Heijden, H.F.M. van der
Die, C.E. van
Bussink, J.
Beijnen, J.H.
Huitema, A.D.
Tjan-Heijnen, V.C.

January 2008

Contains fulltext : 71334.pdf (publisher's version ) (Closed access)In advanced no...

Dose and dose-intensity of chemotherapy, studies in small cell lung cancer

Tjan-Heijnen, Vivianne Christine Gerarda

January 2002

Contains fulltext : 19175_doseandoi.pdf (publisher's version ) (Open Access)Withou...

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

Ardizzoni, A.
Tjan-Heijnen, V.C.
Postmus, P.E.
Buchholz, E.
Biesma, B.
Karnicka-Mlodkowska, H.
Dziadziuszko, R.
Burghouts, J.T.M.
Meerbeeck, J.P. van
Gans, S.
Legrand, C.
Debruyne, C.
Giaccone, G.
Manegold, C.

January 2002

Item does not contain fulltextPURPOSE: To assess the impact on survival of increasing dose-intensity...

Received Dose-Intensity: A Randomized Trial of Weekly Chemotherapy With and Without Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer

R. L. Souhami
P. G. Harper

October 2016

Purpose: A prospective randomized trial to deter-mine if granulocyte colony-stimulating factor (G-CS...

Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.

Timmer-Bonte, J.N.H.
Tjan-Heijnen, V.C.

January 2006

Contains fulltext : 49340timmer-bonte.pdf (publisher's version ) (Closed access

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia

Vellenga, E.
Uyl-de Groot, C.A.
Wit, R. de
Keizer, H.J.
Löwenberg, B.
Haaft, M.A. ten
Witte, T.J.M. de
Verhagen, C.A.H.
Stoter, G.J.
Rutten, F.F.H.
Mulder, N.H.
Smid, W.M.
Vries, E.G.E. de

January 1996

Contains fulltext : 22848___.PDF (publisher's version ) (Open Access

Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor

Gurney, H.
Anderson, H.
Radford, J.
Potter, M. R.
Swindell, R.
Steward, W.
Kamthan, A.
Chang, J.
Weiner, J.
Thatcher, N.
Crowther, D.

January 1992

The effect of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) was assess...

Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy?

Croockewit, A.J.
Koopmans, P.P.
Pauw, B.E. de

January 1996

Contains fulltext : 22983___.PDF (publisher's version ) (Open Access

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for research and treatment of cancer leukemia cooperative group

Zittoun, R.
Suciu, S.
Mandelli, F.
Witte, T.J.M. de
Thaler, J.
Stryckmans, P.
Hayat, M.
Peetermans, M.
Cadiou, M.
Solbu, G.
Petti, M.C.
Willemze, R.

January 1996

Contains fulltext : 23963___.PDF (publisher's version ) (Open Access

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.

Aapro, M.S.
Cameron, D.
Pettengell, R.
Bohlius, J.
Crawford, J.
Ellis, M.
Kearney, N.
Lyman, G.H.
Tjan-Heijnen, V.C.
Walewski, J.A.
Weber, D.C.
Zielinski, C.

January 2006

Contains fulltext : 50078tjan-heijnen.pdf (publisher's version ) (Closed access)Ch...

Supplemental material for Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level

Hassam Baig (5741096)
Barbara Somlo (5741099)
Melissa Eisen (2544973)
Scott Stryker (5741102)
Mark Bensink (799890)
Phuong K Morrow (5741105)

September 2018

Supplemental material for Appropriateness of granulocyte colony-stimulating factor use in patients r...

Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.

Timmer-Bonte, A.
Boo, T.M. de
Smit, H.J.
Biesma, B.
Wilschut, F.A.
Cheragwandi, S.A.
Termeer, A.
Hensing, C.A.
Akkermans, J.
Adang, E.M.M.
Bootsma, G.P.
Tjan-Heijnen, V.C.

January 2005

Contains fulltext : 47915_pub.pdf (publisher's version ) (Closed access) ...

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

Ardizzoni, A.
Tjan-Heijnen, V.C.
Postmus, P.E.
Buchholz, E.
Biesma, B.
Karnicka-Mlodkowska, H.
Dziadziuszko, R.
Burghouts, J.T.M.
Meerbeeck, J.P. van
Gans, S.
Legrand, C.
Debruyne, C.
Giaccone, G.
Manegold, C.

January 2002

PURPOSE: To assess the impact on survival of increasing dose-intensity (DI) of cyclophosphamide, dox...

An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn.

Tjan-Heijnen, V.C.
Wagener, D.J.T.
Postmus, P.E.

January 2002

Item does not contain fulltextBACKGROUND: The survival in untreated small-cell lung cancer (SCLC) is...

Review of the value of colony stimulating factors for prophylaxis of febrile neutropenic episodes in adult patients treated for haematological malignancies.

Levenga, T.H.
Timmer-Bonte, J.N.H.

January 2007

Contains fulltext : 51747timmer-bonte.pdf (publisher's version ) (Closed access)Ch...

Prophylactic G-CSF and antibiotics enable a significant dose-escalation of triplet-chemotherapy in non-small cell lung cancer.

Timmer-Bonte, J.N.H.
Punt, C.J.A.
Heijden, H.F.M. van der
Die, C.E. van
Bussink, J.
Beijnen, J.H.
Huitema, A.D.
Tjan-Heijnen, V.C.

January 2008

Contains fulltext : 71334.pdf (publisher's version ) (Closed access)In advanced no...

Dose intensification of chemotherapy and the role of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in small cell lung cancer

Abstract

Extracted data

Dose intensification of chemotherapy and the role of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in small cell lung cancer

Abstract

Extracted data

Related items

Related items